datamatters24/research-document-archive huggingface dataset:
I 
113TH CONGRESS 
1ST SESSION H. R. 3070 
To amend section 501 of the Foreign Intelligence Surveillance Act of 1978 
to reform access to certain business records for foreign intelligence and 
international terrorism investigations, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 9, 2013 
Mr. FITZPATRICK introduced the following bill; which was referred to the 
Committee on the Judiciary, and in addition to the Select Committee on 
Intelligence (Permanent Select), for a period to be subsequently deter-
mined by the Speaker, in each case for consideration of such provisions 
as fall within the jurisdiction of the committee concerned 
A BILL 
To amend section 501 of the Foreign Intelligence Surveil-
lance Act of 1978 to reform access to certain business 
records for foreign intelligence and international ter-
rorism investigations, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘NSA Accountability 
Act’’. 
VerDate Mar 15 2010 
02:34 Sep 10, 2013
Jkt 029060
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3070.IH
H3070
rfrederick on DSK6VPTVN1PROD with BILLS
SEC. 2. REFORMS TO ACCESS TO CERTAIN BUSINESS 
RECORDS FOR FOREIGN INTELLIGENCE AND 
INTERNATIONAL 
TERRORISM 
INVESTIGA-
TIONS. 
(a) IN GENERAL.—Subsection (b)(2)(A) of section 
501 of the Foreign Intelligence Surveillance Act of 1978 
(50 U.S.C. 1861) is amended— 
(1) in the matter preceding clause (i)— 
(A) by inserting ‘‘specific and articulable’’ 
before ‘‘facts showing’’; 
(B) by inserting ‘‘and material’’ after ‘‘are 
relevant’’; and 
(C) by striking ‘‘clandestine intelligence ac-
tivities’’ and all that follows and inserting 
‘‘clandestine intelligence activities and pertain 
only to an individual that is the subject of such 
investigation; and’’; and 
(2) by striking clauses (i) through (iii). 
(b) WITHHOLDING
OF
FUNDS.—Notwithstanding 
any other provision of law, in the case of a violation of 
section 501 of the Foreign Intelligence Surveillance Act 
of 1978 (50 U.S.C. 1861) in a fiscal year, all unobligated 
funds made available for such fiscal year to carry out such 
section shall be withheld for the period beginning on the 
VerDate Mar 15 2010 
02:34 Sep 10, 2013
Jkt 029060
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3070.IH
H3070
rfrederick on DSK6VPTVN1PROD with BILLS
date of such violation and ending on September 30 of such 
fiscal year. 
Æ 
VerDate Mar 15 2010 
02:34 Sep 10, 2013
Jkt 029060
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H3070.IH
H3070
rfrederick on DSK6VPTVN1PROD with BILLS
IV
105TH CONGRESS
2D SESSION
H. CON. RES. 251
Expressing the sense of the Congress that a postage stamp should be issued
to commemorate the life of George Washington and his contributions
to the Nation.
IN THE HOUSE OF REPRESENTATIVES
MARCH 26, 1998
Mr. DAVIS of Virginia (for himself, Mr. MORAN of Virginia), Mr. SCOTT, Mr.
GOODE, Mr. BOUCHER, Mr. SISISKY, Mr. BATEMAN, Mr. WOLF, Mr.
BLILEY, and Mr. GOODLATTE) submitted the following concurrent resolu-
tion; which was referred to the Committee on Government Reform and
Oversight
CONCURRENT RESOLUTION
Expressing the sense of the Congress that a postage stamp
should be issued to commemorate the life of George
Washington and his contributions to the Nation.
Whereas 1999 marks the 200th anniversary of the death of
George Washington;
Whereas George Washington’s extraordinary virtue com-
manded the respect of America’s early leaders, who called
on him to preside over the framing of the Constitution;
Whereas George Washington was an indispensable figure in
the founding of our Nation, and served as our country’s
first commander in chief and President with unparalleled
distinction;
for issuing each patent, or for an unintentionally de-
layed response by the patent owner in a reexamina-
tion proceeding, $1,210 unless the petition is filed
under sections 133 or 151 of this title, in which case
the fee shall be $110.’’.
(c) APPEAL TO THE BOARD OF PATENT APPEALS
AND INTERFERENCES.—Section 134 of title 35, United
States Code, is amended to read as follows:
‘‘§ 134. Appeal to the Board of Patent Appeals and
Interferences
‘‘(a) An applicant for a patent, any of whose claims
has been twice rejected, may appeal from the decision of
the primary examiner to the Board of Patent Appeals and
Interferences, having once paid the fee for such appeal.
‘‘(b) A patent owner in a reexamination proceeding
may appeal from the final rejection of any claim by the
primary examiner to the Board of Patent Appeals and
Interferences, having once paid the fee for such appeal.
‘‘(c) A third-party requester may appeal to the Board
of Patent Appeals and Interferences from the final deci-
sion of the primary examiner favorable to the patentability
of any original or proposed amended or new claim of a
patent, having once paid the fee for such appeal.’’.
(d) APPEAL TO COURT OF APPEALS FOR THE FED-
ERAL CIRCUIT.—Section 141 of title 35, United States
Code, is amended by amending the first sentence to read
as follows: ‘‘An applicant, a patent owner, or a third-party
requester, dissatisfied with the final decision in an appeal
to the Board of Patent Appeals and Interferences under
section 134 of this title, may appeal the decision to the
United States Court of Appeals for the Federal Circuit.’’.
(e) PROCEEDINGS ON APPEAL.—Section 143 of title
35, United States Code, is amended by amending the third
sentence to read as follows: ‘‘In ex parte and reexamina-
tion cases, the Commissioner shall submit to the court in
writing the grounds for the decision of the Patent and
Trademark Office, addressing all the issues involved in the
appeal.’’.
(f) CIVIL ACTION TO OBTAIN PATENT.—Section 145
of title 35, United States Code, is amended in the first
sentence by inserting ‘‘(a)’’ after ‘‘section 134’’.
SEC. 5. EFFECTIVE DATE.
This Act shall take effect on the date that is 6
months after the date of the enactment of this Act and
shall apply to all reexamination requests filed on or after
that effective date.
Æ
I 
113TH CONGRESS 
1ST SESSION H. R. 3071 
To amend the Patient Protection and Affordable Care Act to provide that 
no Government contribution may be made toward the cost of Exchange 
coverage for any Member of Congress or congressional staff. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 9, 2013 
Mr. GINGREY of Georgia introduced the following bill; which was referred to 
the Committee on House Administration 
A BILL 
To amend the Patient Protection and Affordable Care Act 
to provide that no Government contribution may be made 
toward the cost of Exchange coverage for any Member 
of Congress or congressional staff. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘No Special Treatment 
for Congress Act’’. 
VerDate Mar 15 2010 
02:34 Sep 10, 2013
Jkt 029060
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3071.IH
H3071
rfrederick on DSK6VPTVN1PROD with BILLS
SEC. 2. GOVERNMENT CONTRIBUTION NOT PERMITTED. 
Section 1312(d)(3)(D) of the Patient Protection and 
Affordable Care Act (42 U.S.C. 18032(d)(3)(D)) is 
amended— 
(1) by redesignating clause (ii) as clause (iii); 
and 
(2) by inserting after clause (i) the following: 
‘‘(ii) 
GOVERNMENT
CONTRIBUTION 
NOT
PERMITTED.—Notwithstanding any 
provision of chapter 89 of title 5, United 
States Code, or of any other law, no Gov-
ernment contribution under such chapter 
may be made for health benefits obtained 
by any Member of Congress or congres-
sional staff in accordance with clause (i).’’. 
Æ 
VerDate Mar 15 2010 
02:34 Sep 10, 2013
Jkt 029060
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H3071.IH
H3071
rfrederick on DSK6VPTVN1PROD with BILLS
before ‘‘or customs and border protection offi-
cer’’; and 
(B) in subsections (m) and (n), by insert-
ing ‘‘as a Federal Protective Service law en-
forcement officer,’’ before ‘‘or as a customs and 
border protection officer,’’. 
(b) FEDERAL EMPLOYEES RETIREMENT SYSTEM.— 
(1) DEFINITION.—Section 8401 of title 5, 
United States Code, is amended— 
(A) in paragraph (37), by striking ‘‘and’’ 
at the end; 
(B) in paragraph (38), by striking the pe-
riod and inserting ‘‘; and’’; and 
(C) by adding at the end the following: 
‘‘(39) ‘Federal Protective Service law enforce-
ment officer’ means an employee in the Federal Pro-
tective Service of the Department of Homeland Se-
curity— 
‘‘(A) who holds a position within the GS– 
0083, GS–0080, GS–1801, or GS–1811 job se-
ries (determined applying the criteria in effect 
as of September 1, 2007) or any successor posi-
tion; and 
‘‘(B) who are authorized to carry firearms 
and empowered to make arrests in the perform-
VerDate Sep 11 2014 
03:46 Apr 25, 2015
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1851.IH
H1851
smartinez on DSK4TPTVN1PROD with BILLS
SEC. 2. AMENDMENT. 
Section 3(k) of the Food and Nutrition Act of 2008 
(7 U.S.C. 2012(k)) is amended to read as follows: 
‘‘(k) ‘Food’ means a supplemental food of the kind 
prescribed by the Secretary under section 17(b)(14) of the 
Child Nutrition Act of 1966 (42 U.S.C. 1786(b)(14)).’’. 
SEC. 3. EFFECTIVE DATE. 
This Act shall take effect on January 1, 2014. 
Æ 
VerDate Mar 15 2010 
21:40 Sep 12, 2013
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H3073.IH
H3073
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(2) 
QUALIFYING
PHYSICIAN
OR
PRACTI-
TIONER.—The term ‘Medicare participating physi-
cian or practitioner’ means the following: 
‘‘(A) A physician (as defined in section 
1861(r)) who is a participating physician or 
supplier (as defined in section 1842(h)(1)). 
‘‘(B) A practitioner (as defined in section 
1842(b)(18)(C)) who is a participating physi-
cian 
or 
supplier 
(as 
defined 
in 
section 
1842(h)(1)). 
‘‘(f) CONSTRUCTION.—Nothing in this section may be 
construed to remove, limit, or otherwise affect any obliga-
tion of a covered health care professional under the Con-
trolled Substances Act (21 U.S.C. 801 et seq.).’’. 
Æ 
VerDate Mar 15 2010 
03:02 Sep 11, 2013
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H3077.IH
H3077
jbell on DSK7SPTVN1PROD with BILLS
priated such sums as are necessary to carry out 
this section. 
(4) ELECTION.— 
(A) INCUMBENT DEFINED.—For purposes 
of this paragraph, the term ‘‘incumbent’’ means 
an individual who is serving as a Federal Pro-
tective Service law enforcement officer on the 
date of the enactment of this Act. 
(B) NOTICE
REQUIREMENT.—Not later 
than 30 days after the date of enactment of 
this Act, the Director of the Office of Personnel 
Management shall take measures reasonably de-
signed to ensure that incumbents are notified 
as to their election rights under this paragraph, 
and the effect of making or not making a time-
ly election. 
(C) ELECTION
AVAILABLE
TO
INCUM-
BENTS.— 
(i) IN GENERAL.—An incumbent may 
elect, for all purposes, either— 
(I) to be treated in accordance 
with the amendments made by sub-
section (a) or (b), as applicable; or 
VerDate Sep 11 2014 
03:46 Apr 25, 2015
Jkt 049200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H1851.IH
H1851
smartinez on DSK4TPTVN1PROD with BILLS
(J) The Motion Picture Association of
America.
(K) The Alliance of Motion Picture and
Television Producers.
(L) The Screen Actors Guild of America.
(M) The National Association of Theater
Owners.
(N) The American Society of Cinematog-
raphers and the International Photographers
Guild, which shall jointly submit one list of 3
candidates from which a member and alternate
will be selected.
(O) The United States Members of the
International Federation of Film Archives.
(P) The Association of Moving Image Ar-
chivists.
(Q) 
The 
Society 
of 
Composers 
and
Lyricists.
(2) MEMBERS-AT-LARGE.—In addition to the
Members appointed under paragraph (1), the Li-
brarian shall appoint up to 3 members-at-large. The
Librarian shall also select an alternate for each
member at-large, who may attend at Board expense
those meetings which the member at-large cannot
attend.
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘James Madison Con-
gressional Accountability Act’’. 
SEC. 2. HEALTH INSURANCE COVERAGE FOR CERTAIN 
CONGRESSIONAL STAFF AND MEMBERS OF 
THE EXECUTIVE BRANCH. 
Section 1312(d)(3)(D) of the Patient Protection and 
Affordable Care Act (42 U.S.C. 18032(d)(3)(D)) is 
amended— 
(1) by striking the subparagraph heading and 
inserting the following: 
‘‘(D) MEMBERS OF CONGRESS, CONGRES-
SIONAL STAFF, AND POLITICAL APPOINTEES IN 
THE EXCHANGE.—’’; 
(2) in clause (i), in the matter preceding sub-
clause (I)— 
(A) by striking ‘‘and congressional staff 
with’’ and inserting ‘‘, congressional staff, the 
President, the Vice President, and political ap-
pointees with’’; and 
(B) by striking ‘‘or congressional staff 
shall’’ and inserting ‘‘, congressional staff, the 
President, the Vice President, or a political ap-
pointee shall’’; 
(3) in clause (ii)— 
VerDate Mar 15 2010 
03:02 Sep 11, 2013
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3076.IH
H3076
jbell on DSK7SPTVN1PROD with BILLS
HR 1734 RFS
SEC. 114. REPEAL.
The National Film Preservation Act of 1992 (2
U.S.C. 179 and following) is repealed.
TITLE II—THE NATIONAL FILM
PRESERVATION FOUNDATION
ACT
SEC. 201. SHORT TITLE.
This title may be cited as the ‘‘National Film Preser-
vation Foundation Act’’.
SEC. 202. ESTABLISHMENT AND PURPOSE OF FOUNDATION.
(a) ESTABLISHMENT.—There is established the Na-
tional Film Preservation Foundation (hereafter in this
title referred to as the ‘‘Foundation’’). The Foundation
is a charitable and nonprofit corporation and is not an
agency or establishment of the United States.
(b) PURPOSES.—The purposes of the Foundation
are—
(1) to encourage, accept, and administer private
gifts to promote and ensure the preservation and
public accessibility of the nation’s film heritage held
at the Library of Congress and other public and
nonprofit archives throughout the United States;
(2) to further the goals of the Library of Con-
gress and the National Film Preservation Board in
connection with their activities under the National
Film Preservation Act of 1996; and
‘‘(6) Such other Federal officials as the Sec-
retary determines to be appropriate.
‘‘(c) ADVISORY COMMITTEE.—
‘‘(1) IN GENERAL.—The Secretary shall provide
for a committee to provide advice to the Secretary
regarding pediatric prevention research. The mem-
bers of the committee shall be appointed from indi-
viduals who have expertise in pediatric prevention
activities and who, subject to paragraph (2), are not
officers or employees of the Federal Government.
‘‘(2) USE OF EXISTING COMMITTEES.—A Fed-
eral employee may serve as a member of the advi-
sory committee under paragraph (1) if the only Fed-
eral duty of the employee is to serve on one or more
Federal advisory committees, and if the individual,
when first appointed to such a committee, was not
a Federal officer or employee.
‘‘(d) INTERAGENCY PLAN.—The Secretary—
‘‘(1) shall establish a comprehensive plan for
carrying out subsection (a) through the Centers for
Disease Control and Prevention and such other
agencies of the Department as the Secretary deter-
mines to be appropriate; and
‘‘(2) shall periodically review and as appropriate
make revisions in the plan.
V 
113TH CONGRESS 
1ST SESSION H. R. 3079 
For the relief of Jesus Garcia Flores. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 10, 2013 
Mr. PASTOR of Arizona introduced the following bill; which was referred to 
the Committee on the Judiciary 
A BILL 
For the relief of Jesus Garcia Flores. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. PERMANENT RESIDENT STATUS FOR JESUS 
GARCIA FLORES. 
(a) IN GENERAL.—Notwithstanding subsections (a) 
and (b) of section 201 of the Immigration and Nationality 
Act, Jesus Garcia Flores shall be eligible for issuance of 
an immigrant visa or for adjustment of status to that of 
an alien lawfully admitted for permanent residence upon 
filing an application for issuance of an immigrant visa 
under section 204 of such Act or for adjustment of status 
to lawful permanent resident. 
VerDate Mar 15 2010 
01:56 Sep 11, 2013
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3079.IH
H3079
jbell on DSK7SPTVN1PROD with BILLS
(b) ADJUSTMENT OF STATUS.—If Jesus Garcia Flo-
res enters the United States before the filing deadline 
specified in subsection (c), he shall be considered to have 
entered and remained lawfully and shall, if otherwise eligi-
ble, be eligible for adjustment of status under section 245 
of the Immigration and Nationality Act as of the date of 
the enactment of this Act. 
(c) DEADLINE FOR APPLICATION AND PAYMENT OF 
FEES.—Subsections (a) and (b) shall apply only if the ap-
plication for issuance of an immigrant visa or the applica-
tion for adjustment of status is filed with appropriate fees 
within 2 years after the date of the enactment of this Act. 
(d) REDUCTION OF IMMIGRANT VISA NUMBER.— 
Upon the granting of an immigrant visa or permanent res-
idence to Jesus Garcia Flores, the Secretary of State shall 
instruct the proper officer to reduce by 1, during the cur-
rent or next following fiscal year, the total number of im-
migrant visas that are made available to natives of the 
country of the alien’s birth under section 203(a) of the 
Immigration and Nationality Act or, if applicable, the 
total number of immigrant visas that are made available 
to natives of the country of the alien’s birth under section 
202(e) of such Act. 
(e) 
DENIAL
OF
PREFERENTIAL
IMMIGRATION 
TREATMENT
FOR CERTAIN RELATIVES.—The natural 
VerDate Mar 15 2010 
01:56 Sep 11, 2013
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3079.IH
H3079
jbell on DSK7SPTVN1PROD with BILLS
parents, brothers, and sisters of Jesus Garcia Flores shall 
not, by virtue of such relationship, be accorded any right, 
privilege, or status under the Immigration and Nationality 
Act. 
Æ 
VerDate Mar 15 2010 
01:56 Sep 11, 2013
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H3079.IH
H3079
jbell on DSK7SPTVN1PROD with BILLS
505(j) which refers to the drug subject to the section
505(b)(1) approval effective prior to the expiration of 6
months from the earliest date on which an approval of
such application under section 505(b)(2) or section 505(j),
respectively, could otherwise be made effective under the
applicable provisions of this chapter. Nothing in this sub-
section shall affect the ability of the Secretary to make
effective a section 505(b)(2) or section 505(j) approval for
a subject drug if such approval is proper under such sub-
section and is made effective prior to the submission of
the reports of pediatric studies described in subsection (c).
‘‘(c)(1) The Secretary may, pursuant to a written re-
quest for studies after consultation with the sponsor of
an application or holder of an approval for a drug under
section 505(b)(1), agree with the sponsor or holder for the
conduct of pediatric studies for such drug.
‘‘(2) If the sponsor or holder and the Secretary agree
upon written protocols for such studies, the studies re-
quirement of subsection (a) or (b) is satisfied upon the
completion of the studies in accordance with the protocols
and the submission of the reports thereof to the Secretary.
Within 60 days after the submission of the report of the
studies, the Secretary shall determine if such studies were
or were not conducted in accordance with the written pro-
(II) to be treated as if sub-
sections (a) and (b) had never been 
enacted. 
(ii) FAILURE
TO
MAKE
A
TIMELY 
ELECTION.—Failure to make a timely elec-
tion under clause (i) shall be treated in the 
same way as an election made under clause 
(i)(I) on the last day allowable under 
clause (iii). 
(iii) DEADLINE.—An election under 
this subparagraph shall not be effective 
unless it is made at least 14 days before 
the effective date under paragraph (1). 
(5) DEFINITION.—For the purposes of this sub-
section, the term ‘‘Federal Protective Service law en-
forcement officer’’ has the meaning given such term 
by section 8331(33) or 8401(39) of title 5, United 
States Code (as amended by this Act). 
(6) EXCLUSION.—Nothing in this section or 
any amendment made by this section shall be consid-
ered to afford any election or to otherwise apply with 
respect to any individual who, as of the day before 
the date of the enactment of this Act— 
(A) holds a position within the Federal 
Protective Service; and 
VerDate Sep 11 2014 
03:46 Apr 25, 2015
Jkt 049200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H1851.IH
H1851
smartinez on DSK4TPTVN1PROD with BILLS
(B) is considered a law enforcement officer 
for purposes of subchapter III of chapter 83 or 
chapter 84 of title 5, United States Code, by 
virtue of such position. 
Æ 
VerDate Sep 11 2014 
03:46 Apr 25, 2015
Jkt 049200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6301
E:\BILLS\H1851.IH
H1851
smartinez on DSK4TPTVN1PROD with BILLS
‘‘PART O—PREVENTIVE HEALTH RESEARCH
REGARDING CHILDREN
‘‘SEC. 399M. RESEARCH REGARDING CHILDREN AND PRE-
VENTABLE DISEASES, DISORDERS, AND INJU-
RIES.
‘‘(a) IN GENERAL.—The Secretary shall carry out a
program of research regarding preventable diseases, dis-
abilities, and injuries in children, including research on the
causes of death in children. The Secretary may conduct
the research directly or through making grants to public
and nonprofit private entities.
‘‘(b) COLLABORATION WITH RELEVANT AGENCY
HEADS.—The Secretary shall carry out subsection (a) in
collaboration with the following:
‘‘(1) The Director of the Centers for Disease
Control and Prevention.
‘‘(2) The Director of the National Institute of
Child Health and Human Development.
‘‘(3) The Director of the National Center for
Injury Prevention and Control.
‘‘(4) The Director of the Maternal and Child
Health Bureau.
‘‘(5) The Administrator for Health Care Policy
and Research.
105TH CONGRESS
2D SESSION
H. CON. RES. 254
CONCURRENT RESOLUTION
Calling on the Government of Cuba to return to the
United States convicted felon Joanne Chesimard
and all other individuals who have fled the
United States to avoid prosecution or confine-
ment for criminal offenses and who are currently
living freely in Cuba.
† HR 307 EAS 
‘‘(D) establishing protocols to ensure that 
countermeasure reviewers have sufficient train-
ing or experience with countermeasures; 
‘‘(4) maintain teams, composed of Food and 
Drug Administration personnel with expertise on 
countermeasures, including specific countermeasures, 
populations with special clinical needs (including 
children and pregnant women that may use counter-
measures, as applicable and appropriate), classes or 
groups of countermeasures, or other countermeasure- 
related technologies and capabilities, that shall— 
‘‘(A) consult with countermeasure experts, 
including countermeasure sponsors and appli-
cants, to identify and help resolve scientific 
issues related to the approval, licensure, or clear-
ance of countermeasures, through workshops or 
public meetings; and 
‘‘(B) improve and advance the science relat-
ing to the development of new tools, standards, 
and approaches to assessing and evaluating 
countermeasures— 
‘‘(i) in order to inform the process for 
countermeasure approval, clearance, and li-
censure; and